Shenzhen HeiPa Culture Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen HeiPa Culture Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include ZIPVIT and NUTRAVITA. The owner is based in Shenzhen,Guangdong.

2-107, Yihai Road, No. 2033 Shenyan Road

Haishan Street,Yantian District

Shenzhen,Guangdong 518000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NUTRAVITA
NUTRAVITA
Registered 2023
ZIPVIT
ZIPVIT
Registered 2023

Trademark Classifications

Shenzhen HeiPa Culture Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Shenzhen HeiPa Culture Co., Ltd. have?

Shenzhen HeiPa Culture Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Shenzhen HeiPa Culture Co., Ltd. file in?

Shenzhen HeiPa Culture Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Shenzhen HeiPa Culture Co., Ltd.'s most well-known trademarks?

Shenzhen HeiPa Culture Co., Ltd.'s registered trademark portfolio includes well-known marks such as ZIPVIT and NUTRAVITA. These are among 2 currently registered trademarks in the portfolio.

What is Shenzhen HeiPa Culture Co., Ltd.'s trademark registration success rate?

Shenzhen HeiPa Culture Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.